CD9 is an adverse prognostic marker and promising therapeutic target in high-risk pediatric B-precursor acute lymphoblastic leukemia
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListChi Zhang, John Tak Kit Cheung, Kathy Yuen Yee Chan, Han Wang, Toni Ki Fong Man, Karen Li, Chi Kong Li, Kam Tong Leung
Name of Conference24th Congress of the European Hematology Association
Start Date of Conference13/06/2019
End Date of Conference16/06/2019
Place of ConferenceAmsterdam
Country/Region of ConferenceNetherlands
Year2019
Month6
LanguagesEnglish-United States

Last updated on 2019-28-11 at 12:45